125 related articles for article (PubMed ID: 36856377)
1. Application of a burn scar assessment tool for the evaluation of visual scarring following immunocryosurgery for facial basal cell carcinoma.
Gaitanis G; Spyridonos P; Seretis K; Moschovos V; Bassukas ID
Eur J Dermatol; 2022 Nov; 32(6):709-715. PubMed ID: 36856377
[TBL] [Abstract][Full Text] [Related]
2. The Feasibility of Immunocryosurgery in the Treatment of Non-Superficial, Facial Basal Cell Carcinoma That Relapsed after Standard Surgical Excision: An Experience Report from Two Centers.
Gaitanis G; Zampeta A; Tsintzou P; Fillis G; Seretis K; Feldmeyer L; Bassukas I
Curr Oncol; 2022 Nov; 29(11):8475-8482. PubMed ID: 36354728
[TBL] [Abstract][Full Text] [Related]
3. Immunocryosurgery for non-superficial basal cell carcinoma: a pro-spective, open-label phase III study for tumours ≤ 2 cm in diameter.
Gaitanis G; Bassukas ID
Acta Derm Venereol; 2014 Jan; 94(1):38-44. PubMed ID: 23722308
[TBL] [Abstract][Full Text] [Related]
4. Cryosurgery during Imiquimod (Immunocryosurgery) for Periocular Basal Cell Carcinomas: An Efficacious Minimally Invasive Treatment Alternative.
Gaitanis G; Kalogeropoulos CD; Bassukas ID
Dermatology; 2016; 232(1):17-21. PubMed ID: 26583773
[TBL] [Abstract][Full Text] [Related]
5. Immunocryosurgery for non-superficial basal cell carcinomas ≤ 20 mm in maximal diameter: Five-year follow-up.
Gaitanis G; Bassukas ID
J Geriatr Oncol; 2019 May; 10(3):475-478. PubMed ID: 30219274
[TBL] [Abstract][Full Text] [Related]
6. Immunocryosurgery is a safe and feasible treatment for basal cell carcinoma and Bowen disease in renal transplant recipients.
Tsironi T; Gaitanis G; Pappas C; Koutlas V; Dounousi E; Bassukas ID
Dermatol Ther; 2022 May; 35(5):e15405. PubMed ID: 35194902
[TBL] [Abstract][Full Text] [Related]
7. Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application.
Gaitanis G; Nomikos K; Vava E; Alexopoulos EC; Bassukas ID
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1427-31. PubMed ID: 19555364
[TBL] [Abstract][Full Text] [Related]
8. Office-based treatment of basal cell carcinoma with immunocryosurgery: feasibility and efficacy.
Nakuçi M; Bassukas ID
Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(2):35-8. PubMed ID: 23836356
[TBL] [Abstract][Full Text] [Related]
9. New Atrophic Acne Scar Classification: Reliability of Assessments Based on Size, Shape, and Number.
Kang S; Lozada VT; Bettoli V; Tan J; Rueda MJ; Layton A; Petit L; Dréno B
J Drugs Dermatol; 2016 Jun; 15(6):693-702. PubMed ID: 27272075
[TBL] [Abstract][Full Text] [Related]
10. Reliability and Photographic Equivalency of the Scar Cosmesis Assessment and Rating (SCAR) Scale, an Outcome Measure for Postoperative Scars.
Kantor J
JAMA Dermatol; 2017 Jan; 153(1):55-60. PubMed ID: 27806156
[TBL] [Abstract][Full Text] [Related]
11. Intralesional bevacizumab as in-add adjuvant to immunocryosurgery for locally advanced basal cell carcinoma.
Gaitanis G; Bassukas I
J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1117-21. PubMed ID: 25243268
[TBL] [Abstract][Full Text] [Related]
12. Surgical Treatment of Facial Basal Cell Carcinoma: Patient-Based Assessment of Clinical Outcome in a Prospective Cohort Study.
Ofaiche J; Lopez R; Bérard E; André A; Bulai-Livideanu C; Méresse T; Vairel BB; Grolleau JL; Paul C; Meyer N
Dermatology; 2016; 232(5):550-557. PubMed ID: 27676268
[TBL] [Abstract][Full Text] [Related]
13. The Brisbane Burn Scar Impact Profile (child and young person version) for measuring health-related quality of life in children with burn scars: A longitudinal cohort study of reliability, validity and responsiveness.
Simons M; Kimble R; McPhail S; Tyack Z
Burns; 2019 Nov; 45(7):1537-1552. PubMed ID: 31387803
[TBL] [Abstract][Full Text] [Related]
14. Image Perceptual Similarity Metrics for the Assessment of Basal Cell Carcinoma.
Spyridonos P; Gaitanis G; Likas A; Seretis K; Moschovos V; Feldmeyer L; Heidemeyer K; Zampeta A; Bassukas ID
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509205
[TBL] [Abstract][Full Text] [Related]
15. BCC and Immunocryosurgery scar differentiation through computational resolution-enhanced OCT images and skin optical attenuation: A proof-of-concept study.
Pavlou E; Gaitanis G; Bassukas ID; Kourkoumelis N
Exp Dermatol; 2024 Jan; 33(1):e15019. PubMed ID: 38284205
[TBL] [Abstract][Full Text] [Related]
16. The use of the Scar Cosmesis Assessment and rating scale to evaluate the cosmetic outcomes of totally thoracoscopic cardiac surgery.
Huang LC; Chen DZ; Chen LW; Xu QC; Zheng ZH; Dai XF
J Cardiothorac Surg; 2020 Sep; 15(1):250. PubMed ID: 32917246
[TBL] [Abstract][Full Text] [Related]
17. A modified Vancouver Scar Scale linked with TBSA (mVSS-TBSA): Inter-rater reliability of an innovative burn scar assessment method.
Gankande TU; Wood FM; Edgar DW; Duke JM; DeJong HM; Henderson AE; Wallace HJ
Burns; 2013 Sep; 39(6):1142-9. PubMed ID: 23433706
[TBL] [Abstract][Full Text] [Related]
18. Interventions for basal cell carcinoma of the skin.
Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of the Brisbane Burn Scar Impact Profile in adults with burn scars.
Tyack Z; Kimble R; McPhail S; Plaza A; Simons M
PLoS One; 2017; 12(9):e0184452. PubMed ID: 28902874
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the inflammatory cells infiltrating basal cell carcinomas during immunocryosurgery.
Nomikos K; Lampri E; Spyridonos P; Bassukas ID
Arch Dermatol Res; 2019 Aug; 311(6):499-504. PubMed ID: 31115658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
